Bariatric Surgery

Bariatric surgery is indicated in people with severe obesity such as obesity class III (BMI >40) or obesity class II (BMI >35) when associated with other obesity-related conditions (e.g. high blood pressure, sleep apnea, high cholesterol levels, etc).

In case of type 2 diabetes, surgery can be considered in individuals with BMI as low as 30Kg/m2 or 27.5 for Asians) is standard medical therapy of diabetes is not sufficient to achieve adequate control of blood sugar levels.

Severe obesity (Body Mass Index (BMI)>35) is a chronic condition that increases the risk of diabetes, cancer, liver disease, and overall mortality.

Bariatric/metabolic surgery is the most-effective available therapy for severe obesity and results in:

  • Substantial and sustained weight reduction and improved quality of life;

  • Prevention of complications and mortality associated with obesity;

  • Metabolic surgery reduces the risks of heart attack, stroke, diabetes-related mortality and it improves the quality of life;

  • Improvement of sleep apnea and Nonalcoholic Fatty Liver Disease (NASH) – an aggressive form of liver disease that is projected to become the number one cause of liver transplants in the West.
Bariatric Surgery